Statins use and risk of new-onset diabetes in hypertensive patients: a population-based retrospective cohort study in Yinzhou district, Ningbo city, People’s Republic of China

References

• BaigentCKeechAKearneyPMEfficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statinsLancet200536694931267127816214597
   PubMed Web of Science ®Google Scholar
• BaigentCBlackwellLEmbersonJCholesterol Treatment Trialists’ (CTT) CollaborationEfficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trialsLancet201037697531670168121067804
   PubMed Web of Science ®Google Scholar
• BrugtsJJYetginTHoeksSEThe benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trialsBMJ2009339b2376
   Web of Science ®Google Scholar
• RajpathakSNKumbhaniDJCrandallJBarzilaiNAldermanMRidkerPMStatin therapy and risk of developing type 2 diabetes: a meta-analysisDiabetes Care200932101924192919794004
   PubMed Web of Science ®Google Scholar
• SattarNPreissDMurrayHMStatins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsLancet2010375971673574220167359
   PubMed Web of Science ®Google Scholar
• KohKKQuonMJHanSHLeeYKimSJShinEKAtorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patientsJ Am Coll Cardiol201055121209121620298928
   PubMed Web of Science ®Google Scholar
• SabatineMSWiviottSDMorrowDAMcCabeCHCannonCPHigh-dose atorvastatin associated with worse glycemic control: A PROVE-IT TIMI 22 substudyCirculation200411017834
   Web of Science ®Google Scholar
• ThongtangNAiMOtokozawaSEffects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammationAm J Cardiol2011107338739221257003
   PubMed Web of Science ®Google Scholar
• RidkerPMDanielsonEFonsecaFAHRosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinNew Engl J Med2008359212195220718997196
   PubMed Web of Science ®Google Scholar
• CulverALOckeneISBalasubramanianRStatin use and risk of diabetes mellitus in postmenopausal women in the Women’s Health InitiativeArch Intern Med2012172214415222231607
   PubMed Web of Science ®Google Scholar
• SukhijaRPrayagaSMarashdehMEffect of statins on fasting plasma glucose in diabetic and nondiabetic patientsJ Investig Med2009573495499
   PubMed Web of Science ®Google Scholar
• WangPStatin dose in Asians: is pharmacogenetics relevant?Pharmacogenomics201112111605161522044416
   PubMed Web of Science ®Google Scholar
• LiaoJKSafety and efficacy of statins in AsiansAm J Cardiol200799341041417261409
   PubMed Web of Science ®Google Scholar
• LeeERyanSBirminghamBRosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environmentClin Pharmacol Ther200578433034116198652
   PubMed Web of Science ®Google Scholar
• SunYLGregersenHYuanWChinese health care system and clinical epidemiologyClin Epidemiol2017916717828356772
   PubMed Web of Science ®Google Scholar
• HuDYNew guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in ChinaChronic Dis Transl Med201732737429063058
   PubMedGoogle Scholar
• IzzoRde SimoneGChinaliMInsufficient control of blood pressure and incident diabetesDiabetes Care200932584585019223610
   PubMed Web of Science ®Google Scholar
• GressTWNietoFJShaharEWoffordMRBrancatiFLHypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities StudyNew Engl J Med20003421390591210738048
   PubMed Web of Science ®Google Scholar
• AldermanMHCohenHMadhavanSDiabetes and cardiovascular events in hypertensive patientsHypertension19993351130113410334799
   PubMed Web of Science ®Google Scholar
• SowersJREpsteinMFrohlichEDDiabetes, hypertension, and cardiovascular disease: an updateHypertension20013741053105911304502
   PubMed Web of Science ®Google Scholar
• YusufSBoschJDagenaisGCholesterol lowering in intermediate-risk persons without cardiovascular diseaseNew Engl J Med2016374212021203127040132
   PubMed Web of Science ®Google Scholar
• Morales SalinasACocaAOlsenMHClinical perspective on antihypertensive drug treatment in adults with grade 1 hypertension and low-to-moderate cardiovascular risk: an international expert consultationCurr Probl Cardiol201742719822528552207
   PubMed Web of Science ®Google Scholar
• ManciaGFagardRNarkiewiczK2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens20133171281135723817082
   PubMed Web of Science ®Google Scholar
• ZhouZRahmeEAbrahamowiczMPiloteLSurvival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methodsAm J Epidemiol2005162101016102316192344
   PubMed Web of Science ®Google Scholar
• WangJBGuMJShenPBody mass index and mortality: a 10-year prospective study in ChinaSci Rep201663160927546611
   PubMed Web of Science ®Google Scholar
• ZhaoMLinHYuanYPrevalence of pre-diabetes and its associated risk factors in rural areas of Ningbo, ChinaInt J Environ Res Public Health2016138 pii: E808
   Web of Science ®Google Scholar
• YangYZhouXGaoSEvaluation of electronic healthcare databases for post-marketing drug safety surveillance and pharmacoepidemiology in ChinaDrug safety2017411125137
   Web of Science ®Google Scholar
• WangKLLiuCJChaoTFStatins, risk of diabetes, and implications on outcomes in the general populationJ Am Coll Cardiol201260141231123822884288
   PubMed Web of Science ®Google Scholar
• LinZFWangCYShenLJHsiaoFYWuFLLStatin use and the risk for incident diabetes mellitus in patients with acute coronary syndrome after percutaneous coronary intervention: a population-based retrospective cohort study in TaiwanCan J Diabetes201640326426926992286
   PubMed Web of Science ®Google Scholar
• MacedoAFDouglasISmeethLForbesHEbrahimSStatins and the risk of type 2 diabetes mellitus: cohort study using the UK clinical practice pesearch datalinkBMC Cardiovasc Disord2014148525022519
   PubMed Web of Science ®Google Scholar
• LeeJNohYShinSImpact of statins on risk of new onset diabetes mellitus: a population-based cohort study using the Korean National Health Insurance claims databaseTher Clin Risk Manag2016121533154327785041
   PubMed Web of Science ®Google Scholar
• RhaSWChoiBGSeoHSImpact of statin use on development of new-onset diabetes mellitus in Asian populationAm J Cardiol2016117338238726732422
   PubMed Web of Science ®Google Scholar
• SuissaSImmortal time bias in observational studies of drug effectsPharmacoepidemiol Drug Saf200716324124917252614
   PubMed Web of Science ®Google Scholar
• DormuthCRFilionKBPatersonJMHigher potency statins and the risk of new diabetes: multicentre, observational study of administrative databasesBMJ2014348g324424874977
   PubMed Web of Science ®Google Scholar
• PreissDSeshasaiSRWelshPRisk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysisJAMA2011305242556256421693744
   PubMed Web of Science ®Google Scholar
• CarterAAGomesTCamachoXJuurlinkDNShahBRMamdaniMMRisk of incident diabetes among patients treated with statins: population based studyBMJ2013346f261023704171
   PubMed Web of Science ®Google Scholar
• HeSWangSChenXHigher ratio of triglyceride to high-density lipoprotein cholesterol may predispose to diabetes mellitus: 15-year prospective study in a general populationMetabolism2012611303621664631
   PubMed Web of Science ®Google Scholar
• ParilloMRiccardiGDiet composition and the risk of type 2 diabetes: epidemiological and clinical evidenceBr J Nutr200492171915230984
   PubMed Web of Science ®Google Scholar